Showing results (1861-1870 of 3,101) with videos related to
Sort By:
Pageof 311
Expert Review of Anticancer Therapy|July 14, 2007
Clinical and therapeutic significance of aberrant differentiation patterns in bladder cancerPeter C Black, Gordon A Brown, Colin P N DinneyExpert Review of Anticancer Therapy|July 14, 2007
New approaches in systemic treatment of advanced colorectal cancer: the molecular targets eraJaume Capdevila, Guillermo Mendez, Teresa Macarulla, et al.Expert Review of Anticancer Therapy|July 14, 2007
Systemic and global toxicities of head and neck treatmentBarbara A Murphy, Jill Gilbert, Sheila H RidnerExpert Review of Anticancer Therapy|July 1, 2008
Docetaxel in the management of patients with head and neck squamous cell carcinomaJacques Bernier, Conny VrielingExpert Review of Anticancer Therapy|July 1, 2008
Bortezomib in the front-line treatment of multiple myelomaPaul G Richardson, Constantine Mitsiades, Robert Schlossman, et al.Expert Review of Anticancer Therapy|July 1, 2008
Risk factors and clinical outcomes of patients with node-positive muscle-invasive bladder cancerHarman Maxim Bruins, John P SteinExpert Review of Anticancer Therapy|July 1, 2008
Role of the prostaglandin pathway and the use of NSAIDs in genitourinary malignanciesJohn A Taylor, Carol Pilbeam, Andrew NisbetExpert Review of Anticancer Therapy|July 1, 2008
Genetic polymorphisms and endometrial cancer riskLarissa A Meyer, Shannon N Westin, Karen H Lu, et al.Expert Review of Anticancer Therapy|July 24, 2004
Pemetrexed: a novel antifolate agent enters clinical practiceVictoria Kut, Jyoti D Patel, Athanassios ArgirisExpert Review of Anticancer Therapy|July 24, 2004
Role of FDG-PET in the diagnosis and treatment of colorectal liver metastasesBastiaan Wiering, Theo J M Ruers, Wim J G OyenPageof 311